Back to Results
First PageMeta Content
Pharmaceutical sciences / Food and Drug Administration / Clinical trial / Food and Drugs Act / Adverse effect / Oxycodone / Pharmacovigilance / Patient safety / Removal of cannabis from Schedule I of the Controlled Substances Act / Medicine / Health / Pharmacology


Document Date: 2014-07-10 11:19:17

Open Document

File Size: 834,95 KB

Share Result on Facebook

City

York / Vancouver / Toronto / Blainville / Brampton / Sydney / Kingston / London / Windsor / /

Company

The Canadian Agency for Drugs / Canada Post Corporation / /

Continent

Europe / /

Country

Egypt / Canada / United Kingdom / China / New Zealand / United States / /

Currency

USD / /

Event

Product Issues / Product Recall / Environmental Issue / FDA Phase / Person Communication and Meetings / /

Facility

Supreme Court / Plant Breeders' Rights Act / /

Holiday

Easter / /

IndustryTerm

therapeutic product / energy sources / greenhouse gas emissions / pharmaceuticals / oil industry / pharmaceutical strategy / nonaccessible pharmaceutical systems / renewable solutions / oil / sexual services / risk medical devices / pharmaceutical drugs / universal pharmaceutical strategy / /

MedicalCondition

dementia / severe injury / injury / dementia-related diseases / Alzheimer's disease / cuts / potential injury / Lyme disease / related dementia / disease / chronic illness / cut / /

MedicalTreatment

birth control / /

NaturalFeature

Niagara Peninsula / Echo Bay / James Bay / Batchawana Bay / Blind River / Elliot Lake / Pender Island / Brentwood Bay / /

Organization

Supreme Court / Canadian government / Gladstone Secondary School / House / Department of Citizenship and Immigration / New Democrats / Government of Canada / G20 / Vancouver Centre / Standing Committee on Government Operations and Estimates / FDA / Windermere Secondary School / Eric Hamber Secondary School / Canadian Agency for Drugs and Technologies / Liberal Party / hon. / federal government / Sir Charles Tupper Secondary School in Vancouver / House of Commons / Standing Joint Committee for the Scrutiny of Regulations / /

Person

David Tilson / Elizabeth May / Charles Tupper / Kevin Lamoureux / Pierre Jacob / Liam Kynaston / Windermere / Charlie Angus / Mathieu Ravignat / Judy Sgro / Andrew Scheer / Carol Hughes / Rathika Sitsabaiesan / Lysane Blanchette-Lamothe / Malcolm Allen / Aline Lafond / Charmaine Borg / Ted Hsu / Don Davies / Eric Hamber / Dan Albas / Alan Zhou / Matthew Ching / Matthew Kellway / Harold Albrecht / Gladstone / Irene Mathyssen / Hedy Fry / /

Position

Prime Minister / Public Sector Integrity Commissioner / physician / Auditor General / Deputy Speaker / General / Parliamentary Secretary / PUBLIC SECTOR INTEGRITY COMMISSIONER The Speaker / minister / Speaker / MP / Minister of Health / President of the Treasury Board / bill forward / Leader / /

Product

drugs / drug / dangerous and unsafe foods / OxyContin / DRIVING Mr. Harold Albrecht / G20 / /

ProvinceOrState

Ontario / Scarborough / /

PublishedMedium

the Common Drug Review / /

Region

eastern Ontario / /

Technology

ATM / /

SocialTag